Physician profile
Eric N Tabor
NPI 1588627244
$22,331.12
in general payments reported to CMS, 2019-2025
35 companies · $3,478 in 2025
The $3,478 reported for 2025 was more than what 87% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2020: $985 · 2021: $5,245 · 2022: $3,674 · 2023: $4,130 · 2024: $3,432 · 2025: $3,478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,189 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,722 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,188.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,722.10 |
| Education | $128.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $7,477.47 | 2019-2023 | |
| Abbvie INC. | $5,960.28 | 2019-2025 | Botox, Rinvoq, Skyrizi |
| Genzyme Corporation | $1,092.72 | 2019-2025 | |
| Ucb, INC. | $886.63 | 2019-2025 | Bimzelx |
| Pfizer INC. | $837.44 | 2019-2025 | |
| Janssen Biotech, INC. | $681.04 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Mayne Pharma Commercial LLC | $592.83 | 2020-2025 | |
| Amgen INC. | $550.09 | 2020-2025 | Otezla, Otezla |
| Medimetriks Pharmaceuticals, INC. | $506.91 | 2019-2022 | |
| Organogenesis INC. | $439.21 | 2023-2025 | Affinity, Simplimax, Puraply |
| Lilly USA, LLC | $421.26 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $415.46 | 2022-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $345.17 | 2020-2022 | |
| Leo Pharma INC. | $312.85 | 2019-2025 | Adbry, Anzupgo |
| Almirall LLC | $296.58 | 2021-2025 | Klisyri, Seysara |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $253.96 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $241.84 | 2019-2023 | Dupixent |
| Journey Medical Corporation | $224.24 | 2019-2020 | |
| Dermavant Sciences, INC. | $141.72 | 2023 | Vtama |
| Strata Skin Sciences, INC. | $103.45 | 2023-2025 | Xtrac |
| Sanofi-Aventis U.S. LLC | $99.99 | 2020 | |
| Arcutis Biotherapeutics, INC. | $78.57 | 2023-2024 | Zoryve |
| Organon LLC | $71.28 | 2025 | Vtama |
| Epi Health, LLC | $55.19 | 2020-2022 | |
| Incyte Corporation | $50.26 | 2022-2025 | Opzelura |
| Vyne Pharmaceuticals INC. | $42.01 | 2020-2021 | |
| Galderma Laboratories, L.P. | $26.86 | 2021-2022 | |
| Dusa Pharmaceuticals, INC. | $19.64 | 2019 | |
| Merz North America, INC. | $18.57 | 2023 | |
| Promius Pharma LLC | $18.32 | 2019 | |
| Celgene Corporation | $17.41 | 2019 | |
| Botanix Sb INC | $14.86 | 2025 | Sofdra |
| Qiagen, LLC | $13.39 | 2019 | |
| Kerecis Limited | $12.09 | 2022 | |
| Encore Dermatology INC. | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Tabor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.